Medlicott N - Search Results

1

Current enoxaparin dosing guidelines have dubious credibility.

Al-Sallami H, Jordan S, Ferguson R, Medlicott N, Schollum J, Duffull S. Al-Sallami H, et al. Among authors: medlicott n. N Z Med J. 2010 Apr 30;123(1313):62-7. N Z Med J. 2010. PMID: 20581896 Review.

2

Individualising netilmicin dosing in neonates.

Sherwin CM, Broadbent RS, Medlicott NJ, Reith DM. Sherwin CM, et al. Eur J Clin Pharmacol. 2008 Dec;64(12):1201-8. doi: 10.1007/s00228-008-0536-0. Epub 2008 Aug 7. Eur J Clin Pharmacol. 2008. PMID: 18685839

3

Simultaneous modelling of the Michaelis-Menten kinetics of paracetamol sulphation and glucuronidation.

Reith D, Medlicott NJ, Kumara De Silva R, Yang L, Hickling J, Zacharias M. Reith D, et al. Clin Exp Pharmacol Physiol. 2009 Jan;36(1):35-42. doi: 10.1111/j.1440-1681.2008.05029.x. Epub 2008 Aug 26. Clin Exp Pharmacol Physiol. 2009. PMID: 18759860

4

Netilmicin withdrawal: impact on neonates.

Sherwin CM, Svahn S, Broadbent RS, Van Der Linden A, Medlicott NJ, Reith DM. Sherwin CM, et al. N Z Med J. 2008 Oct 17;121(1284):95-7. N Z Med J. 2008. PMID: 18953395 No abstract available.

5

Bleeding events in patients receiving enoxaparin for the management of non-ST-elevation acute coronary syndrome (NSTEACS) at Dunedin Public Hospital, New Zealand.

Al-Sallami H, Ferguson R, Wilkins G, Gray A, Medlicott NJ. Al-Sallami H, et al. N Z Med J. 2008 Nov 7;121(1285):87-95. N Z Med J. 2008. PMID: 19079441

6

A device for the collection of submandibular saliva.

Hanning S, Motoi L, Medlicott N, Swindells S. Hanning S, et al. Among authors: medlicott n. N Z Dent J. 2012 Mar;108(1):4-8. N Z Dent J. 2012. PMID: 22439314

7

The pharmacokinetic profile of intravenous paracetamol in adult patients undergoing major abdominal surgery.

Owens KH, Medlicott NJ, Zacharias M, Curran N, Chary S, Thompson-Fawcett M, Reith DM. Owens KH, et al. Among authors: medlicott nj. Ther Drug Monit. 2012 Dec;34(6):713-21. doi: 10.1097/FTD.0b013e31826a70ea. Ther Drug Monit. 2012. PMID: 23149443 Clinical Trial.

8

Lecithin-based emulsions for potential use as saliva substitutes in patients with xerostomia--viscoelastic properties.

Hanning SM, Yu T, Jones DS, Andrews GP, Kieser JA, Medlicott NJ. Hanning SM, et al. Int J Pharm. 2013 Nov 18;456(2):560-8. doi: 10.1016/j.ijpharm.2013.08.009. Epub 2013 Aug 18. Int J Pharm. 2013. PMID: 23965434

9

The use of lithium as a marker for the retention of liquids in the oral cavity after rinsing.

Hanning SM, Kieser JA, Ferguson MM, Reid M, Medlicott NJ. Hanning SM, et al. Clin Oral Investig. 2014;18(5):1533-7. doi: 10.1007/s00784-013-1141-x. Epub 2013 Nov 22. Clin Oral Investig. 2014. PMID: 24264639

10

Investigation of an anti-activated factor X (anti-Xa) assay for the quantification of enoxaparin in human plasma.

Al-Sallami HS, Medlicott NJ. Al-Sallami HS, et al. J Pharm Pharmacol. 2015 Feb;67(2):209-14. doi: 10.1111/jphp.12333. Epub 2014 Dec 31. J Pharm Pharmacol. 2015. PMID: 25557692

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results